Macrolide-resistant Mycoplasma pneumoniae in paediatric pneumonia

European Respiratory Journal

Volumn 37, Issue 6, 2011, Pages 1522-1524

  Cardinale, F ^a   Chironna, M ^b   Dumke, R ^d   Binetti, A ^a   Daleno, C ^c   Sallustio, A ^b   Valzano, A ^c   Esposito, S ^c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b POLICLINICO   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CIPROFLOXACIN; CLARITHROMYCIN; MEROPENEM; OXYGEN; SALBUTAMOL; SULTAMICILLIN; TEICOPLANIN;

ABSENCE OF SIDE EFFECTS; ANTIBIOTIC RESISTANCE; CASE REPORT; CHILD; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CRYSTALLOID; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; DYSPNEA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; HYPOCAPNIA; HYPOXEMIA; LETHARGY; LETTER; LUNG INFILTRATE; MALAISE; MYCOPLASMA PNEUMONIAE; NEUTROPHILIA; OXYGEN THERAPY; PRESCHOOL CHILD; PRIORITY JOURNAL; TACHYCARDIA; THORAX RADIOGRAPHY;

ANOXIA; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; CHILD; CIPROFLOXACIN; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; LUNG; MACROLIDES; MYCOPLASMA PNEUMONIAE; NEUTROPHILS; OXYGEN; PNEUMONIA, MYCOPLASMA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 79958018594     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00172510     Document Type: Letter

References (11)

1. Principi N, Esposito S. Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory tract infections. Lancet Infect Dis 2001; 1: 334-344. (Pubitemid 33586614)
2. Esposito S, Bosis S, Begliatti E, et al. Acute tonsillopharyngitis associated with atypical bacteria infection in children: natural history and impact of macrolide therapy. Clin Infect Dis 2006; 43: 206-209.
3. Suzuki S, Yamazaki T, Narita M, et al. Clinical evaluation of macrolide-resistant Mycoplasma pneumoniae. Antimicrob Agents Chemother 2006; 50: 709-712. (Pubitemid 43190986)
4. Cao B, Zhao CJ, Yin YD, et al. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China. Clin Infect Dis 2010; 51: 189-194.
5. Wolff BJ, Thacker WL, Schwartz SB, et al. Detection of macrolide resistance in Mycoplasma pneumoniae by real-time PCR and high-resolution melt analysis. Antimicrob Agents Chemother 2008; 52: 3542-3549.
6. Pereyre S, Charron A, Renaudin H, et al. First report of macrolide-resistant strains and description of a novel nucleotide sequence variation in the P1 adhesin gene in Mycoplasma pneumoniae clinical strains isolated in France over 12 years. J Clin Microbiol 2007; 45: 3534-3539. (Pubitemid 350156844)
7. Dumke R, von Baum H, Lück PC, et al. Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany. Clin Microbiol Infect 2010; 16: 613-616.
8. Dumke R, Schurwanz N, Lenz M, et al. Sensitive detection of Mycoplasma pneumoniae in human respiratory tract samples by optimized real-time PCR approach. J Clin Microbiol 2007; 45: 2726-2730. (Pubitemid 47295516)
9. Spuesens EB, van de Kreeke N, Estevao S, et al. Variation in a surface-exposed region of the Mycoplasma pneumoniae P40 protein as a consequence of homologous DNA recombination between RepMP5 elements. Microbiology 2011; 157: 473-483.
10. Dumke R, Lück PC, Noppen C, et al. Culture-independent molecular subtyping of Mycoplasma pneumoniae in clinical samples. J Clin Microbiol 2006; 44: 2567-2570. (Pubitemid 44092428)
11. Kurata S, Taguchi H, Sasaki T, et al. Antimicrobial and immunomodulatory effect of clarithromycin on macrolide-resistant Mycoplasma pneumoniae. J Med Microbiol 2010; 59: 693-701.